ESTRELLA IMMUNOPHARMA, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $-1.1M | $321.7K |
| Jun 2022 | — | $-1.0M | $88.3K |
| Sep 2022 | — | $-3.8M | $73.8K |
| Dec 2022 | — | $-6.5M | $40.8K |
| Mar 2023 | — | $-9.1M | $29.4K |
| Jun 2023 | — | $-11.7M | $2.5M |
| Jul 2023 | — | — | $2.5M |
| Sep 2023 | — | $10.1M | $22.1M |
| Dec 2023 | — | $9.0M | $9.0M |
| Mar 2024 | — | $8.5M | $4.7M |
| Jun 2024 | — | $4.3M | $4.2M |
| Sep 2024 | — | $746.3K | $1.8M |
| Dec 2024 | — | $143.7K | $916.9K |
| Mar 2025 | — | $-1.8M | $421.5K |
| Jun 2025 | — | $-6.1M | $1.3M |
| Sep 2025 | — | $-9.8M | $1.6M |
| Dec 2025 | — | $-10.4M | $1.4M |
| Mar 2026 | — | $-5.3M | $1.9M |
| Jun 2026 | — | $-7.4M | $100.0K |